共 50 条
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties
被引:33
|作者:
Barresi, Elisabetta
[1
]
Tolbatov, Iogann
[2
]
Marzo, Tiziano
[1
,3
]
Zappelli, Elisa
[1
]
Marrone, Alessandro
[4
]
Re, Nazzareno
[4
]
Pratesi, Alessandro
[5
]
Martini, Claudia
[1
,3
]
Taliani, Sabrina
[1
,3
]
Da Settimo, Federico
[1
,3
]
La Mendola, Diego
[1
]
机构:
[1] Univ Pisa, Dept Pharm, Via Bonanno Pisano 6, I-56126 Pisa, Italy
[2] Univ Bourgogne Franche Comte UBFC, Inst Chim Mol Univ Bourgogne ICMUB, Ave Alain Savary 9, Dijon, France
[3] Univ Pisa, CISUP Ctr Integraz Strumentaz Sci, Pisa, Italy
[4] Univ G dAnnunzio, Dipartimento Farm, Via Vestini, I-66100 Chieti, Italy
[5] Univ Pisa, Dept Chem & Ind Chem, Via G Moruzzi 13, I-56124 Pisa, Italy
关键词:
CANCER;
IBUPROFEN;
NAPROXEN;
DRUGS;
PROTEIN;
D O I:
10.1039/d1dt01492g
中图分类号:
O61 [无机化学];
学科分类号:
070301 ;
081704 ;
摘要:
In this paper it is demonstrated that the nature of the ligands of two Ru-2(ii,iii) paddlewheel complexes dramatically affects the overall anticancer properties in cells. Herein, the complex [Ru-2(EB776)(4)Cl] was found to be more active against a glioblastoma model with respect to its isomer [Ru-2(EB106)(4)Cl]. These different effects depend on the steric hindrance, on the allowed conformations of the complexes and on the presence of hydrophilic regions in [Ru-2(EB776)(4)Cl], which overall lead to a lower "steric protection".
引用
收藏
页码:9643 / 9647
页数:5
相关论文